Carderock Capital Management Inc. Raises Position in Abbott Laboratories (NYSE:ABT)
Carderock Capital Management Inc. grew its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 48,842 shares of the healthcare product maker’s stock after acquiring an additional 189 shares during the […]
More Stories
Trump Says US–Iran Ceasefire on ‘Life Support’
By Jack Phillips President Donald Trump on Monday said that a weeks-long ceasefire with Iran is in jeopardy and suggested...
Why Americans Pay High Gas Prices Despite Record U.S. Oil Production and Exports
By Stephen Zogopoulos, USNN World News The Paradox at the Pump As of early May 2026, U.S. regular gasoline prices...
What Time Does Netflix Release Shows? Don’t Miss Another New Release
Many of us like to watch series and movies, but most of the time miss the new release, right? And...
Trump Calls Iran’s Response to Peace Proposal ‘Totally Unacceptable’
By Tom Gantert U.S. President Donald Trump on May 10 rejected Iran’s response to the latest peace proposal pitched by...
Iran Turns to China Rail Link to Bypass US Blockade, but It Has Limited Effect, Analysts Say
By Alex Wu As the U.S. military continues to blockade Iranian ports, Iran has increased overland railway shipment with China...
Passengers Evacuate Cruise Ship Hit by Deadly Hantavirus Outbreak
By Tom Gantert The passengers and crew aboard the MV Hondius exited the hantavirus-stricken cruise ship in the Canary Islands...